Help fund independent journalism.

Building Tools for Tomorrow’s Shareable and Social Democracy

Tara Reade Jill and Hunter Biden

September 8, 2025

Tara Reade Alleges Jill and Hunter Biden Acted as “De Facto Presidents”

Tara Reade, the former Senate aide who accused Joe Biden of sexual assault in the 1990s, has filed a $100 million tort claim against the Department of Justice and FBI, alleging retaliation for going public with her allegations. In a recent interview, Reade said she amended her lawsuit to also …

Thune Democrats obstructing Trump nominees

September 8, 2025

Thune Accuses Democrats of Obstructing Trump Nominees

Senate Majority Whip John Thune (R-SD) is ramping up pressure on Democrats over what he calls unprecedented obstruction of President Donald Trump’s nominees. According to Thune, Democrats have used procedural tactics to stall appointments across federal agencies, leaving critical posts unfilled and forcing Republicans to weigh more drastic measures. “Democrats …

RFK Jr. public health agencies

September 8, 2025

RFK Jr.: Public Health Agencies in Decline

During a recent exchange, Robert F. Kennedy Jr. was asked what he considered the last great success of America’s public health agencies. His answer was stark: “I don’t think there have been successes. I think we’ve seen a 30 or 40 year decline in the agency because it’s been infiltrated …

RSV vaccine safety signals

September 8, 2025

RSV Vaccine Safety Signals Raise Alarming Questions

A new peer-reviewed pharmacovigilance study published in Human Vaccines & Immunotherapeutics analyzed nearly 18,000 adverse event reports tied to the three FDA-approved RSV vaccines — Pfizer’s Abrysvo, GSK’s Arexvy, and Moderna’s mRESVIA. The results raise urgent concerns about vaccine safety, especially for seniors and pregnant women. A Pharmacovigilance Study with …

FDA drug rejection letters

September 6, 2025

FDA Publishes New Drug Rejection Letters

The FDA has released another batch of drug rejection letters, following up on the 200 complete response letters (CRLs) made public earlier this summer. The newly disclosed documents, spanning 2024 and 2025, shed light on the agency’s reasoning behind several high-profile rejections, from psychedelic therapies to ultra-rare disease treatments. The …

Blog Archive